Applied Therapeutics said on Wednesday that the U.S. FDA declined to approve its drug to treat galactosemia, a rare genetic ...
A recent slew of food recalls is raising questions about the government’s ability to ensure food safety. Former FDA official ...
The FDA said on Wednesday that it is investigating reports of blood cancers -- including life-threatening cases of ...
A soup mix recall issued this month has been updated by the U.S. Food and Drug Administration ( FDA) as a Class I risk, the ...
The U.S. Food and Drug Administration is weighing the need for a regulatory action on bluebird bio's gene therapy for a rare ...
The co-leader of President-elect Donald Trump’s initiative to cut government spending has a financial stake in the biotech ...
You can now purchase a test that will tell you whether you are sick with COVID or the flu -- no prescription required.
President-elect Donald Trump’s Friday night news dump of health care nominees included the expected naming of Dr. Marty ...
Outlook Therapeutics’ eye disease drug has failed to match Roche’s Lucentis in a key trial. The biotech brushed off the ...
“Phenylephrine is an oral decongestant and vasoconstrictor,” Valley Health Pharmacist Dr. Aaron Stone. “By that, it means it ...
An FDA complete response letter indicates that an application can't be approved in its current form. Govorestat, the company's lead drug candidate, is also being developed for treatment of sorbitol ...
The seafood salad may be of particular risk to those customers who have an allergy or severe sensitivity to soy, the FDA has ...